EMGALITY
NDC 0002-1436, galcanezumab-gnlm, injection, solution, from Eli Lilly and Company.
- Product NDC
- 0002-1436
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1436 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GALCANEZUMAB120 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-1436-11 | 00002143611 | 1 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01) |
| 0002-1436-61 | 00002143661 | 2 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/33a147be-233a-40e8-a55e-e40936e28db0NADAC price for package 00002143611
GET /v1/drugs/nadac/00002143611
Use it
Look up 0002-1436 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1436 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-1436. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.